Showing results (251-260 of 499) with videos related to
Sort By:
Pageof 50
Mbio|April 8, 2024
Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitorNajing Cao, Yanxing Cai, Xin Huang, et al.Viral Immunology|April 9, 2010
A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunityLanying Du, Guangyu Zhao, Chris C S Chan, et al.Clinical Microbiology Reviews|July 21, 2022
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron VariantHao Zhou, Michelle Møhlenberg, Jigarji C Thakor, et al.Journal of Medical Virology|January 21, 2010
Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese populationDing-Qiang Chen, Yong Zeng, Jie Zhou, et al.Journal of Virology|October 21, 2011
Mutations of Gln64 in the HIV-1 gp41 N-terminal heptad repeat render viruses resistant to peptide HIV fusion inhibitors targeting the gp41 pocketXiaowen Yu, Lu Lu, Lifeng Cai, et al.Frontiers in Microbiology|February 8, 2019
Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to Broad Tissue Tropism With Severe Placental Damage and Fetal DemiseWanbo Tai, Denis Voronin, Jiawei Chen, et al.Virology|July 6, 2005
Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4Qian Zhao, Liying Ma, Shibo Jiang, et al.Journal of Virology|November 1, 2016
Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape MutantsWanbo Tai, Yufei Wang, Craig A Fett, et al.Plos One|September 13, 2012
The conserved residue Arg46 in the N-terminal heptad repeat domain of HIV-1 gp41 is critical for viral fusion and entryXiaoyi Wang, Weiliang Xiong, Xiaochu Ma, et al.Plos One|June 7, 2013
Identification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structureLijun Chao, Lu Lu, Hengwen Yang, et al.Pageof 50